Abiomed began the recall in April. In a letter (PDF) sent to healthcare providers at the time, the company described how in some cases, the purge sidearm of an Impella 5.5 pump may begin to leak ...

What happened Shares of Abiomed (ABMD) soared 50% on Tuesday after the medical device maker struck an acquisition deal with Johnson & Johnson (JNJ 0.24%). So what J&J will make a tender offer for ...

Abiomed's stock has tumbled 29.8% year to date through Monday, while J&J shares have gained 1.7% and the Dow Jones Industrial Average has lost 9.9%.

Strengthens Johnson & Johnson’s MedTech Business with the Addition of Abiomed, a World-Leader in Heart Recovery Transaction to Bring Lifesaving Innovations to More Patients with Unmet Need ...

Abiomed's trailing 12-month price to cash flow multiple is 56.72x, compared to Abbott's 21.51x, Medtronic's 24.98x, Edwards Lifesciences' 52.32x, Boston Scientific's 28.52x, and LivaNova's 49.77x.

Abiomed, Inc. ABMD is scheduled to report first-quarter fiscal 2022 results on Aug 5, before market opens. In the last-reported quarter, the company’s earnings of $1.24 per share surpassed the ...

ABIOMED will report Q4 earnings on April 29. Forecasts of 6 analysts expect earnings of $1.09 per share as opposed to earnings of $0.700 per share from the same quarter last year.

10 stocks we like better than Abiomed When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool ...

Abiomed's AAA financials, including a clean balance sheet and world-class margins can justify a premium in its valuation. Discounting Abiomed's future free cash flows, we derive the stock's ...

(RTTNews) - Abiomed Inc. (ABMD) released a profit for its second quarter that rose from last year. The company's bottom line came in at $62.21 million, or $1.36 per share. This compares with $13. ...

Abiomed has several months of inventory available to ship to hospitals. Production continues with strict controls at Abiomed’s redundant manufacturing facilities in the United States and Germany.